Cambricon(SH:688256) 证券时报·2025-08-19 05:03Market Overview - A-shares showed a slowdown in upward momentum compared to the previous day, with the three major indices experiencing fluctuations but recovering losses quickly. As of the morning close, the Shanghai Composite Index rose by 0.30% to 3739.26 points, the Shenzhen Component Index increased by 0.30%, and the ChiNext Index rose by 0.39%. The North Exchange 50 surged by 3.16%, reaching a new historical high [1][2]. Stock Performance - The market saw strong performances in sectors such as innovative drugs and weight loss drugs, with stocks like Boji Pharmaceutical hitting the daily limit. Additionally, liquor stocks experienced notable gains, with Jiugui Liquor also hitting the daily limit. The robotics sector was active, with Nanfang Precision Engineering reaching the daily limit. Other concepts like CPO, rare earth permanent magnets, and Huawei's HarmonyOS also performed well, while brokerage and insurance sectors showed weakness. Over 3200 stocks rose, with a half-day trading volume of approximately 1.68 trillion yuan [2]. High-Value Stocks - A new high-value stock emerged in the A-share market, with Cambrian-U (688256) breaking the 1000 yuan mark, reaching a peak of 1001.10 yuan per share before retreating below that level. Cambrian-U is now the second highest-priced stock in the A-share market, following Kweichow Moutai, which is priced over 1400 yuan per share [3][5]. Trading Activity - Notably, despite market fluctuations, many individual stocks remained active, with several exceeding 5 billion yuan in trading volume within half a trading day. North Rare Earth and Dongfang Fortune both surpassed 10 billion yuan in trading volume, with North Rare Earth achieving 13.37 billion yuan and a price increase of 7.88% [9][10]. Hong Kong Market - The Hong Kong market experienced slight fluctuations, with the Hang Seng Index hovering above 25,000 points. Stocks such as Zhongsheng Holdings, Hansoh Pharmaceutical, and China Resources Mixc Living saw significant gains, while others like China National Pharmaceutical and BYD Electronics faced declines. Several stocks in the Hong Kong Stock Connect saw price increases exceeding 10% [11][12].